Economic Evaluation of Treatment of HIV With Zidovudine/Stavudine and Tenofovir Regimen: A Cost Effectiveness Study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Efavirenz; Emtricitabine; Lamivudine; Nevirapine; Stavudine; Tenofovir; Zidovudine
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 24 Nov 2014 Biomarkers information updated
- 01 Nov 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 01 Oct 2012 New trial record